Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody.
Kubandova
Zuzana
Z
Mathieu
Sylvain
S
Pourtier
Claire
C
Soubrier
Martin
M
D000212:Acyclovir / Q000627:therapeutic use; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D006801:Humans; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors / Q000276:immunology*; D016896:Treatment Outcome; D014775:Virus Activation
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000998:Antiviral Agents; D019947:Receptors, Interleukin-6; C502936:tocilizumab; D000212:Acyclovir